The George Washington University (GW) Cancer Center has achieved internationally recognized accreditation for cellular therapy and stem cell transplantation from the Foundation for the Accreditation of Cellular Therapy (FACT). This accreditation underscores GW’s commitment to providing lifesaving cancer treatments to patients in the Washington, D.C., region.
“FACT accreditation is the gold standard in cellular therapy and stem cell transplantation,” said Amarendra Neppalli, MD, director of transplant and cellular therapy at the GW Cancer Center. “It reflects our dedication to maintaining the highest standards of quality, procedures for safety and excellent outcomes and ensuring our patients have access to cutting-edge therapies in a safe and supportive environment.”
What is Stem Cell Transplantation?
Stem cell transplantation, also known as bone marrow transplantation, is a procedure in which healthy stem cells are used to replace damaged or diseased bone marrow. It is a critical treatment for blood cancers such as leukemia and lymphoma, myeloma.
GW offers Autologous transplantation, where healthy stem cells are collected from the patient before being able to give high dose chemotherapies to achieve deeper remission.
“Stem cell transplantation can be life-changing for patients with blood cancers,” Dr. Neppalli noted. “It provides a path to recovery and a chance for renewed health.”
A Legacy of Leadership
The GW Cancer Center continues to uphold rigorous standards in cellular therapy and transplantation. FACT accreditation reaffirms the center’s leadership in this complex field.
“Our patients benefit from treatments guided by the latest research and supported by a multidisciplinary team of experts,” said Dr. Neppalli. “We’re proud to offer these advanced therapies close to home, providing hope and healing for our community.”
The recognition further cements GW as a leader in cancer care, offering patients access to the latest advancements in cellular therapy and stem cell transplantation.
